Similarly, the abnormally elevated ACER3 expression is measured in nonalcoholic steatohepatitis, and functionally inhibiting ACER3 could protect livers against inflammation and fibrosis through depressing oxidative stress (Wang et al. 2020). The gene discussed is ACER3; the disease is metabolic dysfunction-associated steatohepatitis.